Chimerix Inc. (NASDAQ: CMRX) Stock Information | RedChip

Chimerix Inc. (NASDAQ: CMRX) Listen to this Section


$1.07
+0.2350 ( +28.14% ) 2.2M

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Market Data


Open


$1.07

Previous close


$0.84

Volume


2.2M

Market cap


$91.43M

Day range


$0.84 - $1.06

52 week range


$0.75 - $1.30

Insider Ownership Transactions

Total Amount Purchased: -292,844.00 | $ -313,343.08

Date Type Amount Purchased Purchaser
2024-02-16 Sale -1744.00 Andriole Michael T.
2024-02-16 Sale -1940.00 LaSpaluto Michelle
2024-02-16 Sale -2660.00 Jakeman David
2024-02-02 Sale -25000.00 LaSpaluto Michelle
2024-02-02 Sale -21875.00 Alrutz Michael Albert
2024-02-02 Sale -28125.00 Melemed Allen S.
2024-02-02 Sale -83750.00 Andriole Michael T.
2024-02-02 Sale -10750.00 Jakeman David
2024-01-02 Sale -100000.00 Decker Lisa Lynn
2023-12-29 Sale -17000.00 Andriole Michael T.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 13 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
4 Insider transactions 1 Jun 21, 2024
8-k 8K-related 45 May 01, 2024
10-q Quarterly Reports 55 May 01, 2024
def Proxies and info statements 24 Apr 26, 2024
8-k 8K-related 15 Mar 21, 2024
4 Insider transactions 1 Mar 21, 2024
3 Insider transactions 2 Mar 21, 2024
8-k 8K-related 46 Feb 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.